1. Mattila T, Vasankari T, Kanervisto M, Laitinen T, Impivaara O, Rissanen H, Knekt P, Jousilahti P, Saarelainen S, Puukka P, Heliövaara M. Association between all-cause and cause-specific mortality and the GOLD stages 1 to 4: a 30-year follow-up among Finnish adults. Accepted for publication in Respiratory Medicine.
  2. Partti K, Vasankari T, Kanervisto M, Perälä J, Saarni SI, Jousilahti P, Lönnqvist J, Suvisaari J. Lung function and respiratory diseases in people with psychosis: population-based study. Br J Psychiatry 2015; 207:37-45.
  3. European Innovation Partnership on Active and Healthy Ageing, Action Plan B3; Mechanisms of the Development of Allergy, WP 10; Global Alliance against Chronic Respiratory Diseases, Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Maesano I, Anto JM, Bachert C, Baena-Cagnani CE, Bai C, Baigenzhin A, Barbara C, Barnes PJ, Bateman ED, Beck L, Bedbrook A, Bel EH, Benezet O, Bennoor KS, Benson M, Bernabeu-Wittel M, Bewick M, Bindslev-Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Bousquet PJ, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos PA, Camuzat T, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chkhartishvili E, Chavannes NH, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Cruz AA, Custovic A, Dahl R, Dahlen SE, De Blay F, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dubakiene R, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Frith P, Furber A, Gaga M, Garcés J, Garcia-Aymerich J, Gamkrelidze A, Gonzales-Diaz S, Gouzi F, Guzmán MA, Haahtela T, Harrison D, Hayot M, Heaney LG, Heinrich J, Hellings PW, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim JR, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Khaltaev N, Kolek V, Kowalski ML, Kull I, Kuna P, Kvedariene V, Le LT, Lodrup Carlsen KC, Louis R, MacNee W, Mair A, Majer I, Manning P, de Manuel Keenoy E, Masjedi MR, Melen E, Melo-Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, N'Diaye M, Nafti S, Nekam K, Neou A, Nicod L, O'Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Robine JM, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Rosado-Pinto J, Ryan D, Samolinski B, Sanchez-Borges M, Schünemann HJ, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, Tellier V, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valiulis A, Valovirta E, Van Ganse E, Vandenplas O, Vasankari T, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wahn U, Wallaert B, Whalley B, Wickman M, Williams DM, Wilson N, Yawn BP, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zhong N, Zidarn M, Zuberbier T. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014; 44:304-323.
  4. Kanervisto M, Vasankari T. Matala sosioekonominen asema ja sen yhteys ahtauttaviin keuhkosairauksiin. Bestpractice Keuhkosairaudet 2013; 2: 18 – 20.
  5. Vasankari T, Pietinalho A, Lertola K, Junnila S, Liippo K. Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme; a cohort study. BMC Fam Pract. 2011;12:97.
  6. Vasankari T, Jousilahti P, Knekt P, Marniemi J, Heistaro S, Liippo K, Heliovaara M. Serum cotinine predicts bronchial obstruction regardless of self reported smoking history. Scand J Public Health. 2011 Jul;39(5):547-552.
  7. Kanervisto M, Saarelainen S, Laitinen T, Vasankari T, Heliövaara M, Jousilahti P. Low socioeconomic status is associated with Chronic Obstructive Airway Diseases: a large population-based study on adults in Finland. Respir Med. 2011 Aug;105(8):1140-1146.
  8. Kinnula V, Vasankari T, Kontula E, Sovijärvi A, Säynäjäkangas O, Pietinalho A. The 10 year COPD Programme in Finland: stopping the trend to increases in hospital stays, mortality and cost. Prim Care Respir J. 2011; 20:178-83.
  9. Pietinalho A, Vasankari T, Kontula E, Säynäjäkangas O, Sovijärvi A, Kinnula V. Keuhkoahtaumataudin esiintyvyyden, sairaalahoidon ja kuolleisuuden lisääntyminen on saatu pysäytetyksi. Suomen Lääkärilehti 2011; 24: 1989-1992.
  10. Vasankari T, Impivaara O, Heliövaara M, Heistaro S, Liippo K, Puukka P, Saarelainen S, Kanervisto M, Jousilahti P. No increase in the prevalence of COPD in two decades. Eur Resp J. 2010; 36: 766-773.
  11. Kanervisto M, Saarelainen S, Vasankari T, Heistaro S, Jousilahti O, Heliövaara M, Paavilainen E. COPD, chronic bronchitis and capability to day-to-day activities: population based study. Chronic Respiratory Disease 2010; 7: 207-215.